Gastroentérologie clinique et biologique, 2008-01, Vol.32 (1 Pt. 1), p.3
2008
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations
- Ist Teil von
- Gastroentérologie clinique et biologique, 2008-01, Vol.32 (1 Pt. 1), p.3
- Ort / Verlag
- France
- Erscheinungsjahr
- 2008
- Quelle
- MEDLINE
- Sprache
- Französisch
- Identifikatoren
- ISSN: 0399-8320DOI: 10.1016/j.gcb.2007.11.001Titel-ID: cdi_pubmed_primary_18341970
- Format
- –
- Schlagworte
- Antineoplastic Agents - adverse effects, Antineoplastic Agents - therapeutic use, Benzenesulfonates - adverse effects, Benzenesulfonates - therapeutic use, Carcinoma, Hepatocellular - drug therapy, Clinical Protocols, Contraindications, Disease-Free Survival, Humans, Liver Neoplasms - drug therapy, Neoadjuvant Therapy, Niacinamide - analogs & derivatives, Palliative Care, Phenylurea Compounds, Protein Kinase Inhibitors - adverse effects, Protein Kinase Inhibitors - therapeutic use, Pyridines - adverse effects, Pyridines - therapeutic use, raf Kinases - antagonists & inhibitors, Randomized Controlled Trials as Topic, Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors, Remission Induction, Survival Rate